- HOME
- AUTOMOTIVE
- BANKING & FINANCE
- BUSINESS & GOVERNMENT
- CHEMICALS
- COMPUTING & ELECTRONICS
- CONSUMER & RETAIL
Find information products concerning the global biotech and pharmaceutical industries.
Browse and buy business information studies, management reports and market research.
| In Vitro DiagnosticsA Global Market OverviewThe In Vitro Diagnostic (IVD) industry has been confronting a range of issues, such as regulations, industry consolidation, reforms in healthcare, low level of technological innovations and ever-changing demographics. Though... | May 2012 | £2,840 |
| Competitive Insights to Protein Kinase Therapeutics in OncologyThe Faster Route to Consider Your Options and Position of OthersThis report represents a new and unique way of stratifying and analyzing the global protein kinase drug pipeline in oncology towards personalized medicine. It will excel your competitive awareness and... | May 2012 | £2,435 |
| Cardiovascular Devices - GlobalThese market research reports offer an in-depth perspective on the actual market situation, trends and future outlook for cardiovascular devices in different countries around the world. The analyses provide essential... | May 2012 | £2,880 |
| Cardiovascular Devices - United StatesThis market research report offers an in-depth perspective on the actual market situation, trends and future outlook for cardiovascular devices in United States. The analysis provides essential market information for... | May 2012 | £405 |
| Sperm Banks in the USIBISWorld Industry ReportThis industry includes facilities that collect and store sperm, primarily from sperm donors. Fertility clinics mainly use sperm banks for artificial insemination purposes.... | Apr 2012 | £520 |
| Respiratory Protection Equipment Manufacturing in the USIBISWorld Industry ReportThis industry manufactures respiratory protection equipment, including respirators, masks and accessories, gas masks, respiration air supplying self-contained breathing apparatus and accessories, respirator filters and accessories, protective films, and powered air-purifying... | Apr 2012 | £520 |
| Global Drug RetailIntroduction Global Drug Retail industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2006-10, and forecast to 2015). The profile also contains descriptions of the... | May 2011 | £185 |
| Global Healthcare ProvidersIntroduction Global Healthcare Providers industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players... | Feb 2012 | £185 |
| In-Vitro Diagnostics (IVD) Market (Clinical Chemistry, Immunoassays, Molecular Diagnostics, Hematology Analyzers & Microbiology Culture) Global Trends & Forecasts To 2016The global in-vitro diagnostics (IVD) market was valued at $44 billion in 2011 and is expected to have a modest growth during the study period. The U.S. represented the biggest... | May 2012 | £2,935 |
| Infectious Disease Molecular Diagnostics Outlook 2015The molecular diagnostics (MDx) market represents one of the fastest growing segments of global IVD industry. The overall market is estimated to have reached by around US$ 5.4 Billion in... | May 2012 | £885 |
| Bangladesh Pharmaceuticals and Healthcare Report Q12012BMI View: Economic growth will aid the development of Bangladesh's pharmaceutical and healthcare sectors as affordability levels increase and fiscal contributions towards healthcare service provision rise. However, due to Bangladesh's... | Jan 2012 | £740 |
| Pharmaceutical Industry in India - Porter's Five Forces Strategy AnalysisThe Indian pharmaceutical industry is one of the fast growing sectors of the Indian economy and has made rapid strides over the years. From being an import dependent industry in... | Jan 2011 | £110 |
| Top 100 Global Pharmaceutical Manufacturers Industry AnalysisThe Global Top 100 Pharmaceutical Industry Report Plimsoll Publishing Ltd. Do you know.... The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels... | Aug 2011 | £820 |
| Global Animal Health Market Report2011 EditionAnimal health is generally related to providing a quality life to the animals. Mainly, the animal health market includes products like, vaccines, antibiotics, anthelmintics, antifungals, parasiticides, and medical feed additives,... | Dec 2011 | £505 |
| The Pharmaceutical Market: PhilippinesTHE PHARMACEUTICAL MARKET: PHILIPPINES - REVIEW The Philippines is projected to be the tenth largest economy in the Asia Pacific region by 2016. High government spending to stimulate the economy has... | Feb 2012 | £620 |
| The Global Advanced Wound Care Market to 2015Competition Intensifies as Healthcare Spending Comes Under PressureThe rapid progress of the NPWT sector has changed this sector fundamentally. This report examines the market, product ranges and growth drivers, and provides market share data by company for... | Apr 2012 | £795 |
| Blockbuster Drugs 2006: Executive OverviewQuickly review the top 10 world's best selling pharmaceutical products in 2006 with this free report. Each blockbuster drug has the following detail: Target / Mechanism of Action Class of Compound Company Therapeutic Area Indication 1st... | Aug 2007 | |
| The Top 60 Manufacturers Of Coronary Stents WorldwideThe first commercially available stent was created by the Argentinean physician, Julio Palmaz. His stent has had a major impact on the management of atherosclerotic arterial disease. Specifically, it has... | Sep 2009 | £345 |
| The Pharmaceutical Market: PakistanTHE PHARMACEUTICAL MARKET: PAKISTAN - REVIEW The macroenvironmental indicators for the Pakistani pharmaceutical market are positive despite economic concerns. Economically, the Economist Intelligence Unit (EIU) projects that Pakistan will be the... | Feb 2012 | £620 |
| Generic Competition, 2009 to 2013The impact of patent expiries on sales of major drugsThe period 2009–13 will see major companies facing very different degrees of exposure to the potential loss of revenue to generics. Eli Lilly, Pfizer, Bristol-Myers Squibb, Merck and Takeda all face the potential loss... | Apr 2009 | £995 |